Bevacizumab in First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by David Miles

By Miles David  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1800-1801

Adis International

Access to resources Recommend Favorite

Bevacizumab [Avastin; Roche] has been launched in the UK as a first-line treatment for metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer

By Keating Gillian M.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 353-360

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F.   Dhillon Sohita  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite

First-Line Treatment Strategies for Elderly Patients with Metastatic Colorectal Cancer

By Meulenbeld Hielke J.   Creemers Geert-Jan  

Drugs & Aging, Vol. 24, Iss. 3, 2007-01 ,pp. : 223-238

Adis International

Access to resources Recommend Favorite